What does €5–10 million buy in European life sciences real estate?
France and Ireland lead the €5–10 million bracket, largely concentrated in point of care and R&D assets across Europe.
4 min read
paid
Life Sciences Real Estate #61
✅ France: TPG Angelo Gordon invests in Paris
✅ Germany: OSRAM-Höfe ensemble in Berlin
🔒 Spain: two deals from Barcelona
🔒 UK: office-to-lab conversion at ARC Oxford
7 min read
Reverse conversions: when science facilities find new purpose
Converting former science facilities to new uses offers investors portfolio protection against tenant risk while unlocking new income streams.
3 min read
members
Life Sciences Real Estate #60
✅ Investment strategy: life sciences real estate in professional portfolios
✅ Chart of the month: EU patent applications
✅ UK labs: new data tool launches in Q4
2 min read
paid
Life Sciences Real Estate #59
✅ Germany: pharma logistics
✅ Netherlands: Legal & General Amsterdam deal
🔒 Spain: Madrid conversion
🔒 UK: Imperial College's scale-up hub
16 min read
paid
Life Sciences Real Estate #58
✅ From bench to beer: where scientists unwind
✅ Branding: the visual language of innovation
🔒 40+ deals: including multiple deals from France, Germany, Spain and the UK
19 min read